Indication: Obstructive Sleep Apnea (OSA)
Investigational Plan for Pivotal THN Study #3 (aura6000 Targeted Hypoglossal Neurostimulation System)
Sub-indication: Intolerance to CPAP
Study Type: Device Study
Principal Investigator: David Winslow, M.D.Norton Pulmonary Specialists
Sponsor: Sponsor: LivaNova, USA, Inc
Learn more at ClinicalTrials.gov
Email for more information: NCRG@nortonhealthcare.org
